[ad_1]
UBS analysts recommend investors focus on the 20% eps CAGR ASML is expected to deliver between 2027 and 2030
[ad_2]
Source link
Looking through to 2027, UBS upgrades ‘quality compounder’ ASML to buy
[ad_1]
UBS analysts recommend investors focus on the 20% eps CAGR ASML is expected to deliver between 2027 and 2030
[ad_2]
Source link